HAL vs OCUL · P/E 9.3, $19.05B cap vs rev $63.7M
Halliburton Company (HAL) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported OCUL revenue for 2024-12-31 was $63.7M. Net income was -$193.5M. Revenue was up 9.0% from 2023-12-31 to 2024-12-31. OCUL currently screens at market cap $1.76B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the HAL and OCUL stock pages for the full models.
Not investment advice.